Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2021

View Archived Issues

"Invisible" T cells bioengineered from human iPSCs

New purine-nucleoside phosphorylase inhibitors identified at IOCB

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent 5-HT2A antagonists/DRD3 agonists

Ribon Therapeutics discovers TIPARP inhibitors

New N-acetyl-beta-D-glucosaminidase inhibitors described by Biogen

Bristol Myers Squibb identifies new TLR7/8/9 antagonists

Promising data from PDAC arm of the ongoing CANFOUR study of nadunolimab plus chemotherapy

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

Long-term reduced dose regimen with sargramostim shows improved safety in patients with PD

New plasma proteomic biomarkers of OCAD among patients with diabetes

HMGCR variant linked to diabetes in premature triple-vessel disease patients

FXIa inhibitor BMS-986177 well tolerated in patients with renal impairment

Pfizer evaluates 20vPnC coadministered with booster dose of COVID-19 vaccine

Pilot study evaluates NT-I7 in progressive multifocal leukoencephalopathy

Phase IIb study of aldafermin in F2/F3 NASH does not meet primary endpoint

SZN-1326 induces mucosal healing in an acute injury model of IBD

FDA approves IND for phase I trial of Scopus' CpG-STAT3siRNA

Cynata begins MEND trial of Cymerus mesenchymal stem cells in respiratory failure

Initial data reported from phase Ib study of Betalutin with rituximab in second-line FL

Nasally administered foralumab studied in secondary progressive multiple sclerosis

Kiromic submits IND for CAR T-cell therapy KB-ISM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...